These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11295947)

  • 21. Diagnostic significance of blood eosinophilia in returning travelers.
    Schulte C; Krebs B; Jelinek T; Nothdurft HD; von Sonnenburg F; Löscher T
    Clin Infect Dis; 2002 Feb; 34(3):407-11. PubMed ID: 11753824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophilia.
    Spry CJ
    Practitioner; 1982 Jan; 226(1363):79-88. PubMed ID: 7079226
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical presentation of patients with eosinophilic inflammation of the esophagus.
    Baxi S; Gupta SK; Swigonski N; Fitzgerald JF
    Gastrointest Endosc; 2006 Oct; 64(4):473-8. PubMed ID: 16996334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fixed drug eruption: state of the art.
    Ozkaya E
    J Dtsch Dermatol Ges; 2008 Mar; 6(3):181-8. PubMed ID: 18076661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clindamycin skin testing has limited diagnostic potential.
    Notman MJ; Phillips EJ; Knowles SR; Weber EA; Shear NH
    Contact Dermatitis; 2005 Dec; 53(6):335-8. PubMed ID: 16364122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification.
    Wolf R; Matz H; Marcos B; Orion E
    Clin Dermatol; 2005; 23(3):311-4. PubMed ID: 15896547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Toxidermatitis after oral pristinamycin].
    Bernard P; Fayol J; Bonnafoux A; Bedane C; Delrous JL; Catanzano G; Bonnetblanc JM
    Ann Dermatol Venereol; 1988; 115(1):63-6. PubMed ID: 2967042
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunohistochemical characterization of cutaneous drug eruptions by STI571.
    Park HJ; Kim HS; Kim HJ; Lee JY; Cho BK; Lee AW; Yoon DY; Cho DH
    J Dermatol Sci; 2005 Apr; 38(1):9-15. PubMed ID: 15795119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe cutaneous adverse drug reaction due to fluconazole.
    Lester LJ; Brantley JS; Kelso RL; Kelly BC; Petitt MS; Wilkerson MG
    J Drugs Dermatol; 2008 Nov; 7(11):1084-7. PubMed ID: 19110744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of skin testing in cutaneous drug eruptions in routine practice.
    Tchen T; Reguiaï Z; Vitry F; Arnoult E; Grange A; Florent G; Bernard P
    Contact Dermatitis; 2009 Sep; 61(3):138-44. PubMed ID: 19780771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Absolute value of eosinophilis in a cube millimeter of peripheral blood following glucagon loading].
    Jablońska-Ulbrych A; Ordyński J
    Pediatr Pol; 1976 Apr; 51(4):391-6. PubMed ID: 1264523
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cutaneous reactions to drugs].
    Mulder WM; Meinardi MM; Bruynzeel DP
    Ned Tijdschr Geneeskd; 2004 Feb; 148(9):415-20. PubMed ID: 15038200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced cutaneous pathology.
    Ramdial PK; Naidoo DK
    J Clin Pathol; 2009 Jun; 62(6):493-504. PubMed ID: 19155238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and histological features of cutaneous drug reactions].
    Collet E; Touraud JP; Justrabo E; Ponnelle T; Sgro C; Lambert D
    Therapie; 2002; 57(3):254-6. PubMed ID: 12422536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug rash with eosinophilia and systemic symptoms induced by valproate and carbamazepine: formation of circulating auto-antibody against 190-kDa antigen.
    Yun SJ; Lee JB; Kim EJ; Quan G; Kim SJ; Won YH; Lee SC
    Acta Derm Venereol; 2006; 86(3):241-4. PubMed ID: 16710584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin testing in delayed reactions to drugs.
    Barbaud A
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):517-35. PubMed ID: 19563995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fixed drug eruption. Current concepts.
    Sehgal VN; Gangwani OP
    Int J Dermatol; 1987 Mar; 26(2):67-74. PubMed ID: 2952612
    [No Abstract]   [Full Text] [Related]  

  • 38. Pemetrexed-Induced Pseudocellulitis Reaction With Eosinophilic Infiltrate on Skin Biopsy.
    Tracey EH; Modi B; Micheletti RG
    Am J Dermatopathol; 2017 Jan; 39(1):e1-e2. PubMed ID: 27415636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fever, eosinophilia, and a rash.
    Obermoser G; Zelger B
    J Am Acad Dermatol; 2006 May; 54(5):913-4. PubMed ID: 16635685
    [No Abstract]   [Full Text] [Related]  

  • 40. DRESS syndrome: a practical approach for primary care practitioners.
    Seth D; Kamat D; Montejo J
    Clin Pediatr (Phila); 2008 Nov; 47(9):947-52. PubMed ID: 18648083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.